Through an independent MTT assay, we demonstrated that KO of ZNF217 markedly impeded the growth of B-ALL cells, which could be fully reversed by overexpression of ZNF217 (Figure 2C-2D), underscoring the high specificity of the ZNF217 sgRNA. The gene discussed is ZNF217; the disease is acute lymphoblastic leukemia.